Skip to main content

Redburn appoints new Head of Pharmaceuticals Research 20 November 2018

London, 20th November 2018 – Redburn (Europe) Ltd, the independent equity research and execution firm, today announces the appointment of Simon Baker as Head of Pharmaceuticals Research. Simon has 18 years’ experience in the Pharmaceuticals sector and joins Redburn from Exane BNP Paribas.

In his new role, Simon will work closely with Ed Ridley-Day, Redburn’s Head of Medical Technology Research, to deliver a first-class Healthcare franchise. The firm is looking to expand the team and is actively recruiting from industry.

Commenting on Simon Baker’s appointment, Robert Miller, Head of Research Services at Redburn said: “Simon is a highly talented and respected analyst whose style of Research is in keeping with Redburn’s fundamental, differentiated approach. We have great ambitions for this team, which includes building a truly global platform.

Simon Baker added: “I am excited to join Redburn, which is a research platform I greatly admire. Pharmaceuticals is an important sector and one for which Redburn has always been well respected. I am looking forward to leading the team and delivering the original research insights that Redburn’s clients expect.”

Simon will be based in Redburn’s London office and will start his new role in Spring 2019.

Click here for full release.